COPD patients’ characteristics, usual care, and adherence to guidelines: the Greek UNLOCK study

References

• GOLDGlobal strategy for the diagnosis, management and prevention of COPD, global initiative for chronic obstructive lung Disease (Gold 2018 report)2018 Available from: https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdfAccessed October 10, 2018
   Google Scholar
• LevyMLQuanjerPHBookerRDiagnostic spirometry in primary care: Proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations: a General Practice Airways Group (GPIAG)1 document, in association with the Association for Respiratory Technology & Physiology (ARTP)2 and Education for Health3 1 www.gpiag.org 2 www.artp.org 3 www.educationforhealth.org.ukPrim Care Respir J200918313014719684995
   PubMedGoogle Scholar
• HajiroTNishimuraKTsukinoMAnalysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981584118511899769280
   PubMed Web of Science ®Google Scholar
• HoltSSheahanDHelmCLittle agreement in gold category using cat and mMRC in 450 primary care COPD patients in New ZealandNPJ Prim Care Respir Med20142411402525056446
   PubMed Web of Science ®Google Scholar
• KimSOhJKimYIDifferences in classification of COPD group using COPD assessment test (cat) or modified medical Research Council (mMRC) dyspnea scores: a cross-sectional analysesBMC Pulm Med20131313523731868
   PubMed Web of Science ®Google Scholar
• VogelmeierCFCrinerGJMartinezFJGlobal strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. Gold executive summaryAm J Respir Crit Care Med2017195555758228128970
   PubMed Web of Science ®Google Scholar
• WedzichaJABanerjiDChapmanKRIndacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPDN Engl J Med2016374232222223427181606
   PubMed Web of Science ®Google Scholar
• Gruffydd-JonesKBrusselleGJonesRErratum: changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: A real-world studyNPJ Prim Care Respir Med2017271700428631719
   PubMed Web of Science ®Google Scholar
• RocheNLepageTBourcereauJTerriouxPGuidelines versus clinical practice in the treatment of chronic obstructive pulmonary diseaseEur Respir J200118690390811829094
   PubMed Web of Science ®Google Scholar
• CorradoARossiAHow far is real life from COPD therapy guidelines? an Italian observational studyRespir Med2012106798999722483189
   PubMed Web of Science ®Google Scholar
• IPCRGMapping of national guidelines used by primary care Available from: https://www.theipcrg.org/display/ResMapping/Mapping+of+national+guidelines+used+by+primary+careAccessed January 30, 2019
   Google Scholar
• MakeBDutroMPPaulose-RamRMartonJPMapelDWUnder-treatment of COPD: a retrospective analysis of US managed care and Medicare patientsInt J Chron Obstruct Pulmon Dis201271922315517
   PubMed Web of Science ®Google Scholar
• HanMKMartinezCHAuDHMeeting the challenge of COPD care delivery in the USA: a multiprovider perspectiveLancet Respir Med20164647352627185520
   PubMed Web of Science ®Google Scholar
• PriceDWestDBrusselleGManagement of COPD in the UK primary-care setting: an analysis of real-life prescribing patternsInt J Chron Obstruct Pulmon Dis2014988990425210450
   PubMed Web of Science ®Google Scholar
• de Miguel-DíezJCarrasco-GarridoPRejas-GutierrezJInappropriate overuse of inhaled corticosteroids for COPD patients: impact on health costs and health statusLung2011189319920621499887
   PubMed Web of Science ®Google Scholar
• Laniado-LaborínRRendónAAlcantar-SchrammJMCazares-AdameRBauerleOSubutilization of COPD guidelines in primary care: a pilot studyJ Prim Care Community Health20134317217623799703
   PubMedGoogle Scholar
• SafkaKAWaldJWangHMcivorLMcivorAGold stage and treatment in COPD: a 500 patient point prevalence studyChronic Obstr Pulm Dis201641455528848910
   PubMed Web of Science ®Google Scholar
• ChavannesNStällbergBLisspersKUnlock: uncovering and Noting long-term outcomes in COPD to enhance knowledgePrim Care Respir J201019440821120443
   PubMedGoogle Scholar
• JonesPWHardingGBerryPDevelopment and first validation of the COPD assessment testEur Respir J200934364865419720809
   PubMed Web of Science ®Google Scholar
• BestallJCPaulEAGarrodRUsefulness of the medical Research Council (MRC) Dyspnoea Scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
   PubMed Web of Science ®Google Scholar
• TsiligianniIGvan der MolenTMoraitakiDAssessing health status in COPD. A head-to-head comparison between the COPD assessment test (cat) and the clinical COPD questionnaire (CCQ)BMC Pulm Med20121212022607459
   PubMed Web of Science ®Google Scholar
• BuhlRCriéeCPKardosPA year in the life of German patients with COPD: the DACCORD observational studyInt J Chron Obstruct Pulmon Dis2016111639164627499620
   PubMed Web of Science ®Google Scholar
• WorthHBuhlRCriéeCPThe ‘real-life’ COPD patient in Germany: The DACCORD studyRespir Med2016111647126775251
   PubMed Web of Science ®Google Scholar
• PartridgeMRKarlssonNSmallIRPatient insight into the impact of chronic obstructive pulmonary disease in the morning: an Internet surveyCurr Med Res Opin20092582043204819569976
   PubMed Web of Science ®Google Scholar
• RocheNSmallMBroomfieldSHigginsVPollardRReal world COPD: association of morning symptoms with clinical and patient reported outcomesCOPD201310667968624127914
   PubMedGoogle Scholar
• MiravitllesMWorthHSoler CataluñaJJObservational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the assess studyRespir Res201415112225331383
   PubMed Web of Science ®Google Scholar
• ArkhipovVArkhipovaDMiravitllesMLazarevAStukalinaECharacteristics of COPD patients according to gold classification and clinical phenotypes in the Russian Federation: the support trialInt J Chron Obstruct Pulmon Dis2017123255326229138554
   PubMed Web of Science ®Google Scholar
• CasanovaCMarinJMMartinez-GonzalezCDifferential effect of modified medical Research Council dyspnea, COPD assessment test, and clinical COPD questionnaire for symptoms evaluation within the new gold staging and mortality in COPDChest2015148115916825612228
   PubMed Web of Science ®Google Scholar
• ZbozinkovaZBarczykATkacovaRPope study: rationale and methodology of a study to phenotype patients with COPD in central and eastern EuropeInt J Chron Obstruct Pulmon Dis20161161162227042048
   PubMed Web of Science ®Google Scholar
• Cabrera LópezCCasanova MacarioCMarín TrigoJMComparison of the 2017 and 2015 global initiative for chronic obstructive lung disease reports. Impact on grouping and outcomesAm J Respir Crit Care Med2018197446346929099607
   PubMed Web of Science ®Google Scholar
• JonesPWAdamekLNadeauGBanikNComparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classificationEur Respir J201342364765423258783
   PubMed Web of Science ®Google Scholar
• WurstKEShuklaAMuellerovaHRespiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort studyCOPD201411552153024945236
   PubMedGoogle Scholar
• BarrechegurenMMonteagudoMFerrerJTreatment patterns in COPD patients newly diagnosed in primary care. A population-based studyRespir Med2016111475326758585
   PubMed Web of Science ®Google Scholar
• PerezXWisniveskyJPLurslurchachaiLBarriers to adherence to COPD guidelines among primary care providersRespir Med2012106337438122000501
   PubMed Web of Science ®Google Scholar
• SalinasGWilliamsonCKalhanRBarriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physiciansInt J Chron Obstruct Pulmon Dis2011617117921468169
   PubMed Web of Science ®Google Scholar
• FodaHBrehmAGoldsteenKInverse relationship between nonadherence to original GOLD treatment guidelines and exacerbations of COPDInt J Chron Obstruct Pulmon Dis20171220921428123293
   PubMed Web of Science ®Google Scholar
• MiravitllesMMayordomoCArtesMTreatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Estudio Observacional de la Limitacion Obstructiva al Flujo aEreoRespir Med199993317317910464874
   PubMed Web of Science ®Google Scholar
• EstebanCMorazaJQuintanaJMUse of medication and quality of life among patients with COPDRespir Med2006100348749516039840
   PubMed Web of Science ®Google Scholar
• López VarelaMVMuiñoAPadillaRP[Treatment of chronic obstructive pulmonary disease in 5 Latin American cities: the PLATINO study]Arch Bronconeumol20084425864 Spanish18361870
   PubMed Web of Science ®Google Scholar
• RennardSDecramerMCalverleyPMImpact of COPD in North America and Europe in 2000: subjects’ perspective of confronting COPD international surveyEur Respir J200220479980512412667
   PubMed Web of Science ®Google Scholar
• AscheCVCLeaderSPlauschinatCAdherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroidsInt J Chron Obstruct Pulmon Dis2012720120922500120
   PubMed Web of Science ®Google Scholar
• GlaabTBanikNRutschmannOTNational survey of guideline-compliant COPD management among pneumologists and primary care physiciansCOPD20063314114817240616
   PubMedGoogle Scholar
• DecramerMBartschPPauwelsRManagement of COPD according to guidelines. A national survey among Belgian physiciansMonaldi Arch Chest Dis2003591628014533285
   PubMedGoogle Scholar
• Izquierdo-AlonsoJLde Miguel-DiezJEconomic impact of pulmonary drugs on direct costs of stable chronic obstructive pulmonary diseaseCOPD20041221522317136989
   PubMedGoogle Scholar
• ChalmersJDTebbothAGayleADeterminants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practiceNPJ Prim Care Respir Med20172714328663549
   PubMed Web of Science ®Google Scholar
• WhitePThorntonHPinnockHOvertreatment of COPD with inhaled corticosteroids – implications for safety and costs: cross-sectional observational studyPLoS One2013810e7522124194824
   PubMed Web of Science ®Google Scholar
• DrivenesEØstremAMelbyeHPredictors of ICS/LABA prescribing in COPD patients: a study from general practiceBMC Family Pract201415142
   Web of Science ®Google Scholar
• WHOThe pursuit of responsible use of medicines: sharing and learning from country experiences Available from: http://www.who.int/medicines/areas/rational_use/en/Accessed January 30, 2019
   Google Scholar
• LangESWyerPCHaynesRBKnowledge translation: closing the evidence-to-practice gapAnn Emerg Med200749335536317084943
   PubMed Web of Science ®Google Scholar